A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy
Clinical trial NCT02783092 · UNKNOWN
Trial details
- NCT number
- NCT02783092
- Sponsor
- Antonio Waldo Zuardi
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-09
- Primary completion
- 2024-07-10
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.